Jefferies Financial Group Inc. Theravance Biopharma, Inc. Transaction History
Jefferies Financial Group Inc.
- $11 Billion
- Q2 2025
A detailed history of Jefferies Financial Group Inc. transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 276,887 shares of TBPH stock, worth $3.89 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
276,887
Previous 21,432
1191.93%
Holding current value
$3.89 Million
Previous $191,000
1498.95%
% of portfolio
0.03%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding TBPH
# of Institutions
138Shares Held
48.1MCall Options Held
0Put Options Held
11.6K-
Madison Avenue Partners, LP New York, NY9.51MShares$134 Million11.23% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$105 Million1.24% of portfolio
-
Newtyn Management, LLC New York, NY4.95MShares$69.5 Million10.56% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$53.1 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$38.8 Million4.49% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $938M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...